Patents
Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
08/2006
08/24/2006WO2005004810A3 Arylsulfonamide derivatives
08/24/2006US20060189810 Novel sulfonamide inhibitors of aspartyl protease
08/24/2006US20060189681 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
08/24/2006US20060189667 PPAR-activating compound and pharmaceutical composition comprising the compound
08/24/2006US20060189657 Difluoroalkyl-subsituted amides such as morpholine-4-carboxylic acid {(S)-1-[(S)-1-(3-cyclopropyl-1,2,4-oxadiazole-5-carbonyl)-propylcarbamoyl]-3,3-difluoro-butyl}-amide; diseases associated wtih cathepsin S, K, and B such as neurodegenerative diseases, osteoporosis, emphysema, viral infection, cancer
08/24/2006US20060189647 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and thereof
08/24/2006US20060189611 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
08/24/2006US20060189589 For therapy of Parkinson, Huntington's chorea, cerebral circulatory disorders, ischemia, cerebral ischemia, apoplexy, cerebral apoplexy, senile dementia, and Alzheimer's disease
08/23/2006EP1692124A1 Biaryl sulfonamides as mmp inhibitors
08/23/2006EP1692117A1 Oxazole derivatives of tetracyclines
08/23/2006EP0837052B1 Bicyclic amino derivatives and pgd 2 antagonist containing the same
08/23/2006CN1823072A Inhibitors of P38 and methods of using the same
08/23/2006CN1821241A Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same
08/23/2006CN1821235A Benzoxazole azo-compound for generating carrier
08/22/2006US7094911 Biphenyl and biphenyl-analogous compounds as integrin antagonists
08/22/2006US7094807 Viricides; hepatitis virus
08/22/2006US7094795 by alkylation of one of the OH groups, stereoselective enzymatic ester formation or ester hydrolysis, and hydrolysis; and alkylation of the other OH group with a 2-phenyl- or heteroaryloxazolylalkyl halide, sulfonate or triflate
08/22/2006US7094794 used for lowering the blood glucose and for the prevention and treatment of diabetes
08/22/2006US7094790 containing a pyrrole ring, e.g., 4-{2-[2-(2-(R)-Methyl-pyrrolidin-1-yl)-ethyl]-benzothiazol-5-yl}-benzonitrile; useful for treating conditions and disorders related to memory and cognition processes, neurological processes, cardiovascular function, and body weight.
08/22/2006CA2240927C Process for production of piperidine derivatives
08/17/2006WO2006086705A1 Substituted bis aryl and heteroaryl compounds as selective 5ht2a antagonists
08/17/2006WO2006085510A1 Remedy for irritable bowel syndrome
08/17/2006WO2005107762A3 Certain chemical entities, compositions, and methods
08/17/2006US20060183918 Beta 2-adrenergic receptor agonists
08/17/2006CA2598429A1 Substituted bis aryl and heteroaryl compounds as selective 5ht2a antagonists
08/16/2006EP1689716A1 Biaryl sulfonamides and methods for using same
08/16/2006EP1689380A2 Method for treating adamts-5-associated disease
08/16/2006EP1689231A2 Insecticidal n-(heteroarylalkyl) alkanediamine derivatives
08/16/2006EP1087941B1 Thiolesters and uses thereof
08/16/2006EP1019075B9 Beta 2-adrenergic receptor agonists
08/15/2006US7091380 Bradykinin B1 antagonists or inverse agonists, for prophylaxis and therapy of pain and inflammation
08/15/2006US7091361 Compounds and synthesis process
08/15/2006US7091360 Reacting nitrogen compounds such as benzoxazole, with grignard reagents to form chemical intermediates used to form cysteine protease inhibitors
08/15/2006US7091230 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders
08/15/2006US7091228 4-[4'-(1,3-Benzothiazol-2-ylamino)-1,1'-biphenyl-4-yl]-2,2-dimethyl-4-oxobutanoic acid and derivatives; inhibition of DGAT-1 (diacylglycerol O-acyltransferase type 1)
08/15/2006US7091225 Substituted oxazoles and thiazoles as hPPAR alpha agonists
08/15/2006US7091223 Autoimmune diseases; anticancer agents
08/15/2006US7091219 Administering an effective amount of bis-sulfonamide hydroxyethyl-amino derivative to a HIV patient to prevent the viral replication
08/10/2006WO2006083924A1 1-acylamino-2-hydroxy-3-amino-w-arylalkanes as renin inhibitors
08/10/2006WO2006083781A1 Antidiabetic bicyclic compounds
08/10/2006WO2006083271A2 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
08/10/2006WO2006082495A1 Peroxisome proliferator activated receptor modulators
08/10/2006WO2006044415A3 Carboxylic acid peri - substituted bicyclics for occlusive artery disease
08/10/2006US20060178366 Compounds for the treatment of inflammatory disorders
08/10/2006US20060177621 O-coordinated metal chelates and their use in optical recording media having high storage capacity
08/10/2006CA2596444A1 1-acylamino-2-hydroxy-3-amino-w-arylalkanes as renin inhibitors
08/10/2006CA2593858A1 Antidiabetic bicyclic compounds
08/10/2006CA2566809A1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
08/09/2006EP1688416A1 Substituted heterocyclic compounds, their process of preparation and pharmaceutical compositions containing them
08/09/2006EP1688413A1 Benzoxazole derivatives for the prophylaxis and treatment of inflammatory bowel diseases
08/09/2006EP1687287A1 A novel process for ezetimibe intermediate
08/09/2006EP1687271A1 A method for the preparation of (2s, 3ar, 7as)-octahydro-1h-indole-2-carboxylic acid as key intermediate in the preparation of trandolapril by reacting a cyclohexyl aziridine with a dialkyl malonate
08/09/2006EP0877733B1 Process for production of piperidine derivatives
08/09/2006CN1816545A Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof
08/09/2006CN1816534A Oxazolidinone antibiotics and derivatives thereof
08/09/2006CN1816531A Preparation and use of aryl alkyl acid derivatives for the treatment of obesity
08/08/2006US7087784 Process to prepare oxazolidinones
08/08/2006US7087732 Nucleotides and analogs having photoremovable protecting groups
08/08/2006US7087644 Cardiovascular disorders; stimulant of guanylate cyclase ; therapy for liver fibrosis
08/08/2006US7087642 Inhibitors of IMPDH enzyme
08/08/2006US7087601 Psychological disorders; anxiolytic agents; antidepressants; analgesics ; schizophrenia
08/08/2006US7087593 Psychological disorder treatments that increase the activity of cholinergic receptors
08/08/2006CA2200707C Novel prostaglandin synthase inhibitors
08/03/2006WO2006080407A1 Ppar-activating compound
08/03/2006WO2005060456A8 Method for treating adamts-5-associate disease
08/03/2006US20060173057 Methods of treating factor VIIa-associated conditions with compounds having an amine nucleus
08/03/2006US20060171881 Compounds with high monoamine transporter affinity
08/03/2006CA2592116A1 Anti-inflammatory medicaments
08/02/2006EP1686127A1 New heterocyclylmethyl-substituted pyrazole derivatives and their use for treating cardiovascular diseases
08/02/2006EP1685119A1 N-acylsulfonamide apoptosis promoters
08/02/2006EP1685095A1 Method for the production of organic salts containing bis(perfluoroalkyl)phosphinate anions
08/02/2006EP1684750A2 2-aminoaryloxazole compounds as tyrosine kinase inhibitors
08/02/2006CN1812977A Substituted carboxylic acids
08/01/2006US7084162 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
08/01/2006US7084160 2-Amino-(imidazole, thiazole, or oxazole) derivatives; tyrosine kinase, endothelial growth factor, angiogenesis and fibroblast growth factor inhibitors; anticarcinogenic and antidiabetic agents
08/01/2006US7084149 Anticancer agents; antitumor agents
08/01/2006US7083864 For use in the areas of indicators, displays, backlight, electrophotography, illumination sources, recording light sources, exposure illuminants, reading light sources, beacons, signboards and interiors
08/01/2006CA2245823C Farnesyl transferase inhibitors
08/01/2006CA2189456C Substituted aromatic thiocarboxylic acid amides and their use as herbicides
07/2006
07/27/2006WO2006077206A1 New 3-phenylpropionic acid derivatives and their use as ppar- gamma rezeptor liganden
07/27/2006WO2006066173A3 Novel mch receptor antagonists
07/27/2006US20060166990 Novel aminobenzophenone compounds
07/27/2006US20060166981 Novel compounds for use in weight loss and appetite suppression in humans
07/27/2006US20060166961 Cell adhesion inhibitors
07/26/2006EP1682540A1 Azolidinecarbonitriles and their use as dpp-iv inhibitors
07/26/2006EP1682538A1 Biaryl linked hydroxamates: preparation and pharmaceutical applications
07/26/2006EP1682524A1 Novel keto-oxadiazole derivatives as cathepsin inhibitors
07/26/2006EP1682515A1 Method for the production of fluoromethyl-substituted heterocycles
07/26/2006EP1682127A1 Thiazoles and oxazoles useful as modulators of atp-binding cassette transporters
07/26/2006EP1682117A1 2-azetidinones as anti-hypercholesterolemic agents
07/26/2006EP1549713B1 Synergistic uv absorber combination
07/26/2006CN1809917A Assembly for bonding a semiconductor die to substrate with oxazoline derivative bearing an electron donor or acceptor functional group
07/26/2006CN1809541A Aniline derivatives
07/26/2006CN1809531A Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators
07/26/2006CN1266197C Method for applying polymeric lens coating
07/26/2006CN1266140C Process for preparing oxazolines from tetrahydrofurans
07/26/2006CN1266138C Gyrase imhibitors and uses thereof
07/26/2006CN1266118C Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides
07/26/2006CN1266112C Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
07/25/2006US7081537 Process for the electrophilic substitution of thiazolidines or oxazolidines
1 ... 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 ... 210